840 results on '"Segal, Jodi B."'
Search Results
102. Thiazolidinediones and Macular Edema: Comment on “Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes”
103. Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect
104. Differential Association of Race With Treatment and Outcomes in Medicare Patients Undergoing Diverticulitis Surgery
105. An Update on Comparative Effectiveness and Safety of Medications for Type 2 Diabetes
106. Older patients with diverticulitis have low recurrence rates and rarely need surgery
107. Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
108. Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease
109. Frailty Measurement Using Administrative Data in Older Patients With Cardiovascular Disease
110. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
111. Brand versus Generic: Addressing Non-Adherence, Secular Trends and Non-Overlap
112. Evaluation of Bedside Delivery of Medications Before Discharge: Effect on 30-Day Readmission
113. Securing Social Security Disability Insurance (SSDI): Overcoming Challenges
114. Association Between Treatment by Fraud and Abuse Perpetrators and Health Outcomes Among Medicare Beneficiaries
115. Faculty Involvement in Translational Research and Interdisciplinary Collaboration at a US Academic Medical Center
116. Medication Utilization and Annual Health Care Costs in Patients With Type 2 Diabetes Mellitus Before and After Bariatric Surgery
117. Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
118. Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A
119. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports
120. What Can the VA Teach Us About Implementing Proven Advances into Routine Clinical Practice?
121. Need for comparative effectiveness research to address clinical questions in hematology
122. Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
123. Brand vs. Generic: Addressing Non-Adherence, Secular Trends, and Non-Overlap
124. Supplemental Material, 820050_Appendix_1_and_Appendix_2 - Determinants of Generic Drug Substitution in the United States
125. Motivational Factors for Choosing Treatment Destinations for Patients from the United Arab Emirates Seeking Medical Treatment Overseas during 2009-2012:Results from Knowledge Attitudes and Perception Survey 2012
126. Weight-Based Low-Molecular-Weight Heparin versus Weight-Based Intravenous Unfractionated Heparin
127. Current Diagnosis of Venous Thromboembolism in Primary Care: A Clinical Practice Guideline from the American Academy of Family Physicians and the American College of Physicians
128. Management of Venous Thromboembolism: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
129. Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline
130. Venous Thromboembolism Occurs Infrequently in Meningioma Patients Receiving Combined Modality Prophylaxis
131. Hospitalization Rates and Costs of Care of Patients With Sickle-Cell Anemia in the State of Maryland in the Era of Hydroxyurea
132. Duration of Vitamin \K Antagonist Therapy for Venous Thromboembolism: A Systematic Review of the Literature
133. High Prevalence and Correlates of Low Bone Mineral Density in Young Adults With Sickle Cell Disease
134. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review
135. D-dimer testing reduced the need for ultrasonographic imaging in outpatients with suspected deep venous thrombosis
136. Preoperative acute normovolemic hemodilution: a meta-analysis
137. Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
138. Concentrations of B vitamins and homocysteine in children with sickle cell anemia
139. Outpatient therapy with low molecular weight Heparin for the treatment for the treatment of Venous Thromboembolism: A review of efficay, safety, and costs
140. Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism
141. Limited evidence for the benefits of anticoagulation treatment for non-rheumatic atrial fibrillation
142. Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs
143. Efficacy of Agents for Pharmacologic Conversion of Atrial Fibrillation and Subsequent Maintenance of Sinus Rhythm: A Meta-Analysis of Clinical Trials
144. The Evidence Regarding the Drugs Used for Ventricular Rate Control
145. Setting an agenda for comparative effectiveness systematic reviews in CKD care
146. Understanding Geographic Variation in Systemic Overuse Among the Privately Insured
147. Association of Metformin Initiation and Risk of Asthma Exacerbation. A Claims-based Cohort Study
148. Segal and Varadhan Respond to “Estimation With Claims-Based Frailty Indexes”
149. If we recognize heterogeneity of treatment effect can we lessen waste?
150. Frailty Among Older Adults With Acute Myocardial Infarction and Outcomes From Percutaneous Coronary Interventions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.